Skip to main content
. 2004 Dec;48(12):4813–4821. doi: 10.1128/AAC.48.12.4813-4821.2004

TABLE 1.

Activities of HCV-371 against HCV NS5B polymerases from different isolates of genotypes 1a, 1b, 3a, and 4

Genotype and enzyme isolate HCV-371 IC50 ± SDa (μM) Amino acid sequence divergence from genotype 1b BK
% No. of changes
Genotype 1b
    BK 0.3 ± 0.1 (n = 51)
    4a 0.4 ± 0.3 (n = 14) 3.4 19
    320-10-3 0.5 ± 0.3 (n = 8) 4.4 25
    320-3-1 0.4 ± 0.2 (n = 12) 4.6 27
    BB7 0.4 ± 0.2 (n = 15) 3.7 22
    320-2-1 0.5 ± 0.2 (n = 14) 4.2 25
    J4 0.4 ± 0.1 (n = 6) 4.7 28
    FC 1-20 0.5 ± 0.6 (n = 17) 4.7 27
Genotype 1a
    9606 4.8 ± 2.7 (n = 14) 11.5 67
    A5 1.4 ± 0.8 (n = 15) 11.5 68
    207-248 0.6 ± 0.2 (n = 16) 11.3 66
    207-221 0.7 ± 0.4 (n = 15) 11.4 64
    207-247 1.0 ± 0.5 (n = 16) 11.8 69
Genotype 3a
    167-A1 1.8 ± 1.3 (n = 22) 24.7 144
Genotype 4 17.8 ± 8.0 (n = 3) 21.5 126
a

Inhibitory activities are expressed as the mean IC50 ± standard deviation. n, number of determinations.